Grandview Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,319	Closed	-$200K	–	143
2025 Q2	$200K	Sell	4,319 -562	-12%	-$27.6K	0.06%	134
2025 Q1	$298K	Buy	4,881 +19	+0.4%	+$1.11K	0.11%	101
2024 Q4	$275K	Buy	+4,862	New	+$272K	0.1%	103
2024 Q2	–	Sell	-5,687	Closed	-$308K	–	61
2024 Q1	$308K	Sell	5,687 -34	-0.6%	-$1.73K	0.14%	88
2023 Q4	$294K	Sell	5,721 -1,975	-26%	-$104K	0.15%	86
2023 Q3	$447K	Buy	+7,696	New	+$472K	0.26%	70
2023 Q2	–	Sell	-8,156	Closed	-$565K	–	67
2023 Q1	$565K	Sell	8,156 -757	-8%	-$53.4K	0.33%	64
2022 Q4	$641K	Buy	8,913 +2	+0%	+$151	0.4%	59
2022 Q3	$633K	Sell	8,911 -630	-7%	-$45.7K	0.4%	60
2022 Q2	$735K	Buy	9,541 +344	+4%	+$26.2K	0.41%	57
2022 Q1	$672K	Sell	9,197 -206	-2%	-$13.8K	0.28%	67
2021 Q4	$586K	Buy	+9,403	New	+$552K	0.24%	78
2021 Q3	–	Sell	-15,484	Closed	-$1.03M	–	70
2021 Q2	$1.03M	Sell	15,484 -7,641	-33%	-$498K	0.57%	46
2021 Q1	$1.46M	Sell	23,125 -3,057	-12%	-$190K	0.78%	36
2020 Q4	$1.62M	Sell	26,182 -613	-2%	-$37.7K	1.06%	29
2020 Q3	$1.61M	Sell	26,795 -2,632	-9%	-$158K	1.31%	21
2020 Q2	$1.73M	Buy	+29,427	New	+$1.76M	1.51%	19